Concentrix Financial Statements (CNXC)
|
|
|
|
Report date
|
|
|
16.02.2021 |
28.01.2022 |
30.11.2022 |
27.01.2023 |
29.01.2024 |
|
04.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
4 720 |
5 587 |
6 324 |
6 324 |
7 115 |
|
9 536 |
|
Operating Income, bln rub |
|
|
39.6 |
301.6 |
640.2 |
365.5 |
661.3 |
|
638.4 |
|
EBITDA, bln rub |
? |
|
579.2 |
831.9 |
674.5 |
981.1 |
1 117 |
|
1 119 |
|
Net profit, bln rub |
? |
|
164.8 |
405.6 |
435.0 |
435.0 |
313.8 |
|
164.4 |
|
|
OCF, bln rub |
? |
|
507.6 |
514.2 |
|
600.7 |
678.0 |
|
668.3 |
|
CAPEX, bln rub |
? |
|
171.3 |
149.1 |
|
140.0 |
180.5 |
|
182.9 |
|
FCF, bln rub |
? |
|
336.3 |
365.1 |
|
460.7 |
497.5 |
|
485.4 |
|
Dividend payout, bln rub
|
|
|
0.000 |
13.1 |
|
53.4 |
63.5 |
|
60.9 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
3.23% |
0.00% |
12.3% |
20.2% |
|
37.1% |
|
|
OPEX, bln rub |
|
|
1 353 |
1 397 |
1 617 |
1 617 |
1 917 |
|
2 454 |
|
Cost of production, bln rub |
|
|
3 058 |
3 618 |
4 067 |
4 067 |
4 537 |
|
6 444 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
48.3 |
23.0 |
70.1 |
70.1 |
201.0 |
|
326.5 |
|
|
Assets, bln rub |
|
|
5 178 |
5 046 |
6 670 |
6 670 |
12 492 |
|
12 208 |
|
Net Assets, bln rub |
? |
|
2 302 |
2 620 |
2 696 |
2 696 |
4 143 |
|
4 169 |
|
Debt, bln rub |
|
|
1 145 |
802.0 |
2 224 |
2 224 |
4 942 |
|
4 912 |
|
Cash, bln rub |
|
|
152.7 |
182.0 |
145.4 |
145.4 |
295.3 |
|
246.2 |
|
Net debt, bln rub |
|
|
992.5 |
620.0 |
2 079 |
2 079 |
4 647 |
|
4 665 |
|
|
Ordinary share price, rub |
|
|
80.0 |
166.0 |
122.4 |
122.4 |
94.0 |
|
79.1 |
|
Number of ordinary shares, mln |
|
|
51.6 |
51.4 |
51.4 |
51.4 |
53.8 |
|
64.7 |
|
|
Market cap, bln rub |
|
|
4 128 |
8 525 |
6 285 |
6 285 |
5 057 |
|
5 117 |
|
EV, bln rub |
? |
|
5 121 |
9 145 |
8 363 |
8 363 |
9 703 |
|
9 782 |
|
Book value, bln rub |
|
|
-333 |
151 |
-1 194 |
-1 194 |
-3 740 |
|
-3 398 |
|
|
EPS, rub |
? |
|
3.19 |
7.90 |
8.47 |
8.47 |
5.83 |
|
2.54 |
|
FCF/share, rub |
|
|
6.52 |
7.11 |
0.00 |
8.97 |
9.25 |
|
7.51 |
|
BV/share, rub |
|
|
-6.45 |
2.94 |
-23.3 |
-23.3 |
-69.5 |
|
-52.6 |
|
|
EBITDA margin, % |
? |
|
12.3% |
14.9% |
10.7% |
15.5% |
15.7% |
|
11.7% |
|
Net margin, % |
? |
|
3.49% |
7.26% |
6.88% |
6.88% |
4.41% |
|
1.72% |
|
FCF yield, % |
? |
|
8.15% |
4.28% |
0.00% |
7.33% |
9.84% |
|
9.49% |
|
ROE, % |
? |
|
7.16% |
15.5% |
16.1% |
16.1% |
7.57% |
|
3.94% |
|
ROA, % |
? |
|
3.18% |
8.04% |
6.52% |
6.52% |
2.51% |
|
1.35% |
|
|
P/E |
? |
|
25.0 |
21.0 |
14.4 |
14.4 |
16.1 |
|
31.1 |
|
P/FCF |
|
|
12.3 |
23.3 |
|
13.6 |
10.2 |
|
10.5 |
|
P/S |
? |
|
0.87 |
1.53 |
0.99 |
0.99 |
0.71 |
|
0.54 |
|
P/BV |
? |
|
-12.4 |
56.4 |
-5.26 |
-5.26 |
-1.35 |
|
-1.51 |
|
EV/EBITDA |
? |
|
8.84 |
11.0 |
12.4 |
8.52 |
8.69 |
|
8.74 |
|
Debt/EBITDA |
|
|
1.71 |
0.75 |
3.08 |
2.12 |
4.16 |
|
4.17 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
|
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
3.63% |
2.67% |
0.00% |
2.21% |
2.54% |
|
1.92% |
|
| Concentrix shareholders |
